These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 26135856)

  • 1. Reliability of Virtual Screening Methods in Prediction of PDE4B-inhibitor Activity.
    Shubina V; Niinivehmas S; Pentikainen OT
    Curr Drug Discov Technol; 2015; 12(2):117-26. PubMed ID: 26135856
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacophore modeling, 3D-QSAR and docking study of 2-phenylpyrimidine analogues as selective PDE4B inhibitors.
    Tripuraneni NS; Azam MA
    J Theor Biol; 2016 Apr; 394():117-126. PubMed ID: 26804643
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New insights into PDE4B inhibitor selectivity: CoMFA analyses and molecular docking studies.
    Guariento S; Bruno O; Fossa P; Cichero E
    Mol Divers; 2016 Feb; 20(1):77-92. PubMed ID: 26290462
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A combination of pharmacophore modeling, atom-based 3D-QSAR, molecular docking and molecular dynamics simulation studies on PDE4 enzyme inhibitors.
    Tripuraneni NS; Azam MA
    J Biomol Struct Dyn; 2016 Nov; 34(11):2481-92. PubMed ID: 26587754
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exploring the Role of Water Molecules in the Ligand Binding Domain of PDE4B and PDE4D: Virtual Screening Based Molecular Docking of Some Active Scaffolds.
    Singh P; Mishra M; Agarwal S; Sau S; Iyer AK; Kashaw SK
    Curr Comput Aided Drug Des; 2019; 15(4):334-366. PubMed ID: 30394213
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structure-based design of selective phosphodiesterase 4B inhibitors based on ginger phenolic compounds.
    Xing M; Akowuah GA; Gautam V; Gaurav A
    J Biomol Struct Dyn; 2017 Oct; 35(13):2910-2924. PubMed ID: 27608741
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structure based virtual screening to identify selective phosphodiesterase 4B inhibitors.
    Gangwal RP; Damre MV; Das NR; Dhoke GV; Bhadauriya A; Varikoti RA; Sharma SS; Sangamwar AT
    J Mol Graph Model; 2015 Apr; 57():89-98. PubMed ID: 25687765
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacophore modeling, 3D-QSAR, and docking study of pyrozolo[1,5-a]pyridine/4,4-dimethylpyrazolone analogues as PDE4 selective inhibitors.
    Tripuraneni NS; Azam MA
    J Mol Model; 2015 Nov; 21(11):289. PubMed ID: 26499496
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discover natural compounds as potential phosphodiesterase-4B inhibitors via computational approaches.
    Li J; Zhou N; Liu W; Li J; Feng Y; Wang X; Wu C; Bao J
    J Biomol Struct Dyn; 2016 May; 34(5):1101-12. PubMed ID: 26159554
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Docking Studies of Curcumin and Analogues with Various Phosphodiesterase 4 Subtypes.
    Yi YX; Gaurav A; Akowuah GA
    Curr Drug Discov Technol; 2020; 17(2):248-260. PubMed ID: 30332967
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 3D QSAR pharmacophore, CoMFA and CoMSIA based design and docking studies on phenyl alkyl ketones as inhibitors of phosphodiesterase 4.
    Gaurav A; Singh R
    Med Chem; 2012 Sep; 8(5):894-912. PubMed ID: 22741782
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design, synthesis and biological evaluation of novel tetrahydroisoquinoline derivatives as potential PDE4 inhibitors.
    Song G; Zhao D; Hu D; Li Y; Jin H; Cui Z
    Bioorg Med Chem Lett; 2015 Oct; 25(20):4610-4. PubMed ID: 26320621
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prediction of Novel Anoctamin1 (ANO1) Inhibitors Using 3D-QSAR Pharmacophore Modeling and Molecular Docking.
    Lee YH; Yi GS
    Int J Mol Sci; 2018 Oct; 19(10):. PubMed ID: 30336555
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessing protein-ligand binding modes with computational tools: the case of PDE4B.
    Çifci G; Aviyente V; Akten ED; Monard G
    J Comput Aided Mol Des; 2017 Jun; 31(6):563-575. PubMed ID: 28534194
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In silico exploration of c-KIT inhibitors by pharmaco-informatics methodology: pharmacophore modeling, 3D QSAR, docking studies, and virtual screening.
    Chaudhari P; Bari S
    Mol Divers; 2016 Feb; 20(1):41-53. PubMed ID: 26416560
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Integrating Multiple Receptor Conformation Docking and Multi Dimensional QSAR for Enhancing Accuracy of Binding Affinity Prediction.
    Radhika V; Jaraf HA; Kanth SS; Vijjulatha M
    Curr Comput Aided Drug Des; 2017; 13(2):127-142. PubMed ID: 28103770
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis, Pharmacological Profile and Docking Studies of New Sulfonamides Designed as Phosphodiesterase-4 Inhibitors.
    Nunes IK; de Souza ET; Cardozo SV; Carvalho VF; Romeiro NC; Silva PM; Martins MA; Barreiro EJ; Lima LM
    PLoS One; 2016; 11(10):e0162895. PubMed ID: 27695125
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of potential PKC inhibitors through pharmacophore designing, 3D-QSAR and molecular dynamics simulations targeting Alzheimer's disease.
    Iqbal S; Anantha Krishnan D; Gunasekaran K
    J Biomol Struct Dyn; 2018 Nov; 36(15):4029-4044. PubMed ID: 29182053
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacophore generation, atom-based 3D-QSAR, molecular docking and molecular dynamics simulation studies on benzamide analogues as FtsZ inhibitors.
    Tripathy S; Azam MA; Jupudi S; Sahu SK
    J Biomol Struct Dyn; 2018 Sep; 36(12):3218-3230. PubMed ID: 28938860
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of estrogen receptor α ligands with virtual screening techniques.
    Niinivehmas SP; Manivannan E; Rauhamäki S; Huuskonen J; Pentikäinen OT
    J Mol Graph Model; 2016 Mar; 64():30-39. PubMed ID: 26774287
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.